| Brand Name | TRAPEZOID TIBIAL TRAY SZ 3F/2T |
| Common Device Name | PROSTHESIS, KNEE, PATELLOFEMOROTIBIAL, SEMI-CONSTRAINED, CEMENTED, POLYMER/METAL |
| Manufacturer (Section D) |
| EXACTECH, INC. |
| 2320 nw 66 court |
| gainesville FL 32653 |
|
| Manufacturer (Section G) |
| EXACTECH, INC |
| 2320 nw 66th ct |
|
| gainesville FL 32653 |
|
| Manufacturer Contact |
|
julia
goldberg
|
| 2320 nw 66th ct |
| gainesville, FL 32653
|
|
| MDR Report Key | 25670543 |
| Report Number | 1038671-2026-00819 |
| Device Sequence Number | 17542049 |
| Product Code |
JWH
|
| UDI-Device Identifier | 10885862047656 |
| UDI-Public | 10885862047656 |
| Combination Product (Y/N) | N |
| Initial Reporter State | FL |
| Initial Reporter Country | US |
| PMA/510(K) Number | K933610 |
| Number of Events Summarized | 1 |
| Summary Report (Y/N) | N |
| Device Implanted Year | 2011 |
| Device Explanted Year | 2012 |
| Serviced by Third Party (Y/N) | N |
| Reporter Type |
Manufacturer
|
| Report Source |
Consumer,Health Professional,Company Representative |
| Initial Reporter Occupation |
Non-Healthcare Professional
|
| Type of Report
| Initial |
| Report Date (Section B) |
06/30/2026 |
| 1 Device was Involved in the Event |
|
| 1 Patient was Involved in the Event |
|
| Is this an Adverse Event Report? |
Yes
|
| Is this a Product Problem Report? |
Yes
|
| Operator of Device |
Health Professional
|
| Device Expiration Date | 03/15/2016 |
| Device Catalogue Number | 204-04-32 |
| Was Device Available for Evaluation? |
No
|
| Type of Report(Section G) | Thirty-Day |
| Initial Date Received by Manufacturer | 02/28/2023 |
| Initial Report FDA Received Date | 06/30/2026 |
| Date Device Manufactured | 03/17/2011 |
| Is the Device Labeled for Single Use? (Y/N) |
Yes
|
Is This a Single-Use Device that was Reprocessed and Reused on a Patient? (Y/N) |
No
|
| Usage of Device |
Initial
|
| Patient Sequence Number | 1 |
Concomitant Medical Products and Therapy/Usage Dates | SEE H11 |
| Outcome Attributed to Adverse Event |
Hospitalization;
Required Intervention;
|
| Patient Sex | Female |
|
|